Advertise on Healthcare Report
What's next in coronavirus stimulus negotiations...
Dr. Birx warns U.S. in new phase of coronavirus pandemic with ‘extraordinarily widespread’ cases...
Surprise billing fix faces major hurdles in last-minute push...
HHS calls for congressional action on surprise medical bills but doesn't pick a side...
Sanofi and GSK land $2.1 billion deal
Pfizer, BioNTech score deal to supply 120M vaccine doses to Japan
J&J Vaccine Protects Monkeys From Covid With Single Shot
'So far, so good' on leading COVID vaccine, says AstraZeneca
Moderna Vaccine Test in Monkeys Shows Promise
NYT: Is Telemedicine Here to Stay?
Medicaid managed care rates on state chopping blocks, with Centene and Molina at risk...
Regence launches data-sharing initiatives with MultiCare, OHSU...
SNFs to get $750 million pay boost in 2021...
Some providers face daunting repayment deadline for Medicare advance loans...
Allscripts sells EPSi business to Strata Decision Technology for $365M...
HIMSS pushes back 2021 conference to August...
Prospect Medical, which says it would top Prime Healthcare’s offer by $50 million, wants to reopen the bankruptcy bidding process for St. Francis Medical Center...
Molina rakes in $276M in Q2 profit, falling short of Wall Street expectations...
Oscar Health unveils $0 Virtual Primary Care program, 2021 expansion plans...
Riding virtual care surge spawned by the pandemic, Teladoc Health revenues top $240M...
Telehealth made up almost half of all Medicare beneficiaries' primary care use in April...
SOC Telemed to Merge with Healthcare Merger Corp...
Cerner's Q2 revenue down 7%, earnings climb 6%...
Fresenius cuts 2020 outlook to reflect pandemic impact...
Cigna profit and revenue top estimates...
CVS builds out digital health program with five more companies...
CMS: Part D premiums likely to increase slightly in 2021...
BCBS MA expands dentistry telehealth coverage during pandemic...
Virtual behavioral health could expand access to care for 53M Americans, report finds...
CORONAVIRUS
Britain to roll out millions of 90-minute coronavirus tests...
This tiny Texas company is running most of the drive-thru Covid-19 testing in the US...
Boris Johnson pauses England's coronavirus reopening...
Trump urges recovered COVID-19 patients to donate plasma...
FDA says it would clear a coronavirus vaccine so long as it’s safe and at least 50% effective...
U.S. records a coronavirus death every minute as total surpasses 150,000...
Trump launches "Embers Strategy" in coronavirus hotspots...
‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast
Reliance Medical Group CEO: Virtual office will 'eventually generate more revenue' than regular clinic...
As Covid-19 surges, researchers amass lung scans to build AI systems for patient care...
FOLLOW HEALTHCARE REPORT ON TWITTER...
JOIN HEALTHCARE REPORT'S DAILY EMAIL LIST HERE...
Next big COVID-19 treatment may be manufactured antibodies...
Varian sold to Siemens Healthineers in $16.4B all-cash deal...
Gilead Shows the Dangers of Covid-19 Drug Mania...
Sanofi formally investigated over epilepsy drug Depakine...
Rival drugmakers Amgen, AbbVie and Takeda launch joint trial of medicines for COVID-19...
Eli Lilly Studies Experimental Covid-19 Drug in Nursing Homes...
Indian Billionaires Bet Big on Head Start in Coronavirus Vaccine Race...
If Oxford’s Covid-19 Vaccine Succeeds, Layers of Private Investors Could Profit...
Merck aims to start ‘large pivotal’ studies on coronavirus treatment in September...
Merck profit beats estimates on resilient Keytruda demand...
Remdesivir maker Gilead Sciences sees 10% drop in second-quarter sales as demand for non-coronavirus drugs falls...
Takeda Pharma raises profit forecast as it focuses on core drug businesses...
Baxter takes $180M revenue hit in thick of COVID-19...
Bristol Myers resubmits cancer cell therapy, lifting investors' chance at payout...
Thrive raises $257M Series B round for registration study of blood test for early cancer detection...
AstraZeneca Earnings Beat Estimates...
MARWOOD: Life Sciences Investment in the Era of COVID-19 Part 2 of 3: Public Equity...
Scientists get closer to blood test for Alzheimer's disease...
23andMe and GSK Head to Clinical Trials With Cancer Drug...
Glaxo Forecast for 2020 Hinges on Vaccination Rate Recovery...
Advertise on Healthcare Report
